The international and domestic research trends of targeted therapy in bladder cancer: a bibliometric analysis of the past three decades

1

Targeted therapy has become a crucial treatment for bladder cancer, driven by advancements in molecular biotechnology and understanding oncogenic mechanisms.
2

A bibliometric analysis of publications from 1994 to 2024 revealed an upward trend in research output for targeted therapy in bladder cancer.
3

The USA and the University of Texas System were identified as leading contributors to English publications in the field of targeted therapy for bladder cancer.
4

Research hotspots included keywords such as 'phase-ii trial', 'cell line', and 'EGF receptor' for English publications, and 'migration', 'cell proliferation', and 'drug resistance' for Chinese publica
5

Future research will focus on drug management for metastatic bladder cancer and strategies to overcome drug resistance in targeted therapy.

1